BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 8514271)

  • 1. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.
    Knudsen GM; Schmidt J; Almdal T; Paulson OB; Vilstrup H
    Hepatology; 1993 Jun; 17(6):987-92. PubMed ID: 8514271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetrical transport of amino acids across the blood-brain barrier in humans.
    Knudsen GM; Pettigrew KD; Patlak CS; Hertz MM; Paulson OB
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):698-706. PubMed ID: 2384542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
    Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
    Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of essential nutrients across the blood-brain barrier of individual structures.
    Hawkins RA
    Fed Proc; 1986 Jun; 45(7):2055-9. PubMed ID: 3519289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the double-indicator technique for measurement of blood-brain barrier permeability in humans.
    Knudsen GM
    Cerebrovasc Brain Metab Rev; 1994; 6(1):1-30. PubMed ID: 8186068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
    Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
    Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aromatic and branched chain amino acids after porto-caval anastomosis: plasma and brain regional levels in the rat (author's transl)].
    Dussini N; Zanchin G; Rigotti P; Chiandetti L; Vassanelli P; Battistin L
    Riv Patol Nerv Ment; 1978; 99(4):235-43. PubMed ID: 752183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo aminoacid transport in the brain of the rat with porto-caval anastomosis (author's transl)].
    Zanchin G; Rigotti P; Bettineschi F; Vassanelli P; Battistin L
    Riv Patol Nerv Ment; 1978; 99(3):178-88. PubMed ID: 752909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
    Jones EA; Schafer DF; Ferenci P; Pappas SC
    Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain extraction and distribution of 99mTc-bicisate in humans and in rats.
    Knudsen GM; Andersen AR; Somnier FE; Videbaek C; Hasselbalch S; Paulson OB
    J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S12-8. PubMed ID: 8263066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Variation of plasma amino acids in severe hepatitis with encephalopathy 10 cases].
    Delafosse B; Bouletreau P; Motin J
    Nouv Presse Med; 1977 Apr; 6(14):1207-11. PubMed ID: 16244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic principles in hepatic encephalopathy].
    Gerok W
    Internist (Berl); 1985 Jul; 26(7):377-87. PubMed ID: 2863233
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of lactitol [correction of lactilol] on hepatic encephalopathy and plasma amino-acid imbalance.
    Trovato GM; Catalano D; Carpinteri G; Runcio N; Mazzone O
    Recenti Prog Med; 1995; 86(7-8):299-303. PubMed ID: 7569287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.
    Lockwood AH; Yap EW; Wong WH
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):337-41. PubMed ID: 1997506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy.
    Kumar A; Mittal R; Khanna HD; Basu S
    Pediatrics; 2008 Sep; 122(3):e722-7. PubMed ID: 18725389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid content of diazepam binding inhibitor in chronic hepatic encephalopathy.
    Rothstein JD; McKhann G; Guarneri P; Barbaccia ML; Guidotti A; Costa E
    Ann Neurol; 1989 Jul; 26(1):57-62. PubMed ID: 2549847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma amino acids during the oral glucose tolerance test in hepatic diseases.
    Hijikata Y; Fujinami S; Shiozaki Y; Sameshima Y
    Hepatogastroenterology; 1987 Feb; 34(1):16-8. PubMed ID: 3570138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parenteral feeding of patients with liver cirrhosis with hepatic encephalopathy].
    Ferenci P; Wewalka F
    Infusionsther Klin Ernahr; 1980 Apr; 7(2):72-8. PubMed ID: 6776052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.